SCHEMBL13261837

SCHEMBL13261837

CCOC(=O)C(C(=O)c1ccc(CS(=O)O)cc1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ EPHX2 P34913 2/20 0.38
▸ PPARG P37231 2/20 0.38
▸ MAOB P27338 1/20 0.37
▸ NTRK1 P04629 1/20 0.36
▸ NTRK2 Q16620 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13228087 0.86 CES2 (0.47) CES2THRBMAPTCYP1A2CYP3A4
SCHEMBL13261551 0.83 L3MBTL1 (0.41) MAPTSMN1; SMN2ALDH1A1
SCHEMBL3799335 0.81 CES2 (0.45) CES2MAPTNPSR1
SCHEMBL13261592 0.81 CES2 (0.39) CES2CYP1A2CYP3A4CYP2C19RECQL
SCHEMBL1043810 0.80 CES2 (0.49) CES2THRBMAPTCYP1A2CYP3A4
SCHEMBL30836057 0.80 CES2 (0.49) CES2THRBMAPTCYP1A2CYP3A4
SCHEMBL13261550 0.80 MMP8 (0.35) MAPTCYP1A2CYP3A4CYP2C19RECQL
SCHEMBL13261590 0.80 SLC6A2 (0.38) GAA
SCHEMBL13261545 0.79 SLC6A2 (0.42) MAPTSMN1; SMN2GAAMEN1KMT2A
SCHEMBL13261650 0.79 EPHX2 (0.41) MAPTCYP1A2CYP2C19ALOX12EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781592-B2 Thione derivative, method for the preparation thereof, and pharmaceutical composition containing the same CJ CHEILJEDANG CORPORATION (KR) 2010-08-24 — — US disclosed
US-20080090875-A1 Thione Derivative, Method For The Preparation Thereof, And Pharmaceutical Composition Containing The Same CJC CORPORATION (KR) 2008-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090875-A1 Thione Derivative, Method For The Preparation Thereof, And Pharmaceutical Composition Containing The Same TPMT, TST, CYP3A5 CES2 1617/4885THRB 590/4885MAPT 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback